Table 1.
Clinical and pathological characteristics of the included patients.
| Clinical and pathologic characteristics | Value |
|---|---|
| Progression/Recurrence [n (%)] | |
| Y | 7 (21,8) |
| N | 21 (65,6) |
| NR | 4 (12,5) |
| Grade [n (%)] | |
| G1 | 5 (15,6) |
| G2 | 16 (50) |
| G3 | 10 (31,2) |
| AJCC Pathologic Stage | |
| Stage I | 19 (59,3) |
| Stage II | 5 (15,6) |
| Stage III | 4 (12,5) |
| Stage IV | 2 (6,2) |
| Stage IVB | 1 (3,1) |
| AJCC Pathologic T | |
| T1a | 14 (43,7) |
| T1b | 6 (18,7) |
| T2 | 5 (15,6) |
| T3a | 2 (6,2) |
| T3b | 3 (9,3) |
| T4 | 1 (3,1) |
| AJCC Pathologic N | |
| NX | 3 (9,3) |
| N0 | 22 (68,7) |
| N1 | 3 (9,3) |
| N2 | 3 (9,3) |
| AJCC Pathologic M | |
| MX | 2 (6,2) |
| M0 | 27 (84,3) |
| M1 | 2 (6,2) |
The total of the various pathological characteristics is not equal to 100, as patients who do not have the reported data have been omitted.
Y Yes, N No, AJCC American Joint Committee on Cancer, T Tumor, N Nodes, M Metastasis.